Synovus Financial (SNV)
(Delayed Data from NYSE)
$48.70 USD
-0.69 (-1.40%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $48.71 +0.01 (0.02%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$48.70 USD
-0.69 (-1.40%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $48.71 +0.01 (0.02%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth B Momentum B VGM
Zacks News
Synovus Financial (SNV) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Synovus (SNV) delivered earnings and revenue surprises of 20.83% and 38.35%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
What Makes Synovus Financial (SNV) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Synovus Financial (SNV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Ahead of Synovus (SNV) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Synovus (SNV) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Earnings Preview: Investar (ISTR) Q2 Earnings Expected to Decline
by Zacks Equity Research
Investar (ISTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Synovus Financial (SNV) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Synovus (SNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synovus' (SNV) Organic Expansion Drives Growth, High Costs Ail
by Zacks Equity Research
Synovus (SNV) benefits from the strategic expansion efforts of its banking verticals. However, a rise in expenses is likely to impede bottom-line growth in the near term.
Synovus (SNV) Arm Ratings Affirmed by Moody's, Outlook Stable
by Zacks Equity Research
Moody's rating affirms Synovus' (SNV) subsidiary's ratings with a stable outlook. This shows a balance between the credit headwinds associated with a significant concentration in CRE loans.
Synovus (SNV) to Sell RWA & Reposition Securities Portfolio
by Zacks Equity Research
Synovus (SNV) plans to reduce risk-weighted assets by $2-$2.4 billion in second-quarter 2024 and sell available-for-sale securities with a book value of $1.6 billion.
Synovus (SNV) Q1 Earnings & Revenues Miss, Expenses Rise Y/Y
by Zacks Equity Research
Synovus' (SNV) Q1 results reflect y/y declines in revenues and loan balances, as well as increased expenses and provisions.
Compared to Estimates, Synovus (SNV) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Synovus (SNV) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Synovus Financial (SNV) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Synovus (SNV) delivered earnings and revenue surprises of -20.20% and 2.05%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Unveiling Synovus (SNV) Q1 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Synovus (SNV), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
Hilltop Holdings (HTH) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Hilltop Holdings (HTH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Synovus Financial (SNV) Q1 Earnings Expected to Decline
by Zacks Equity Research
Synovus (SNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synovus (SNV) Rolls Out Accelerate Pay for Business Payments
by Zacks Equity Research
Synovus (SNV) unveils a payment solution, Accelerate Pay, to enable commercial banking clients to initiate account payable payments, while eliminating check payments.
JPMorgan's (JPM) Outlook Upgraded by S&P, Ratings Affirmed
by Zacks Equity Research
S&P Global Ratings upgrade JPMorgan's (JPM) outlook to positive from stable, reflecting the strength of the company's extensive lending-to-trading business.
Outlook on 5 Regional Banks Lowered by S&P on CRE Exposure
by Nikita Kataruka
S&P Ratings downgrades the outlook on First Commonwealth, M&T Bank (MTB), Synovus (SNV), Trustmark (TRMK) and Valley National (VLY) to negative from stable.
Synovus' (SNV) Organic Growth Profile Aids Despite Rising Costs
by Zacks Equity Research
While balance sheet strength and asset portfolio repositioning will aid Synovus' (SNV) organic growth, rising costs and loan portfolio concentration are worrisome.
Is Synovus Financial (SNV) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Synovus (SNV) Is a Great 'Buy the Bottom' Stock Now
by Zacks Equity Research
Synovus (SNV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Is Synovus Financial (SNV) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Can Synovus (SNV) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Synovus (SNV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
5 Stocks Trading Near 52-Week High That Can Climb Further
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like GT, CASY, SNV, ARCH and BK that are seeing price strength have a high chance of carrying the momentum forward.
Fifth Third (FITB) Q4 Earnings Beat, Revenues Decline Y/Y
by Zacks Equity Research
An increase in fee income and lower provisions aid Fifth Third's (FITB) Q4 earnings, while higher expenses act as a headwind.
Huntington (HBAN) Q4 Earnings Beat Estimates, Revenues Dip Y/Y
by Zacks Equity Research
Huntington's (HBAN) Q4 earnings beat estimates on improvement in average loans and deposits. However, lower NII and a rise in expenses are concerning.